Prism Medico & Pharmacy Ltd (PRISMMEDI) is currently trading at 29.48 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Prism Medico and Pharmacy Limited was originally founded in 1985 and engaged in wholesale and retail of animal feed before switching to pharmaceuticals and related products in 2022-23. Since the transition, the company has expanded its core business to include pharmaceuticals, drugs, nutraceuticals, healthcare products, and dietary supplements, signifying a strategic pivot in its operations. Lately, Prism Medico and Pharmacy has experienced challenges in maintaining major operations and focused more on trading activities. In recent efforts, significant changes in its Memorandum of Association have opened avenues for manufacturing and trading pharmaceuticals, potentially marking the beginning of operational revitalization.

Over the past 52 weeks, Prism Medico & Pharmacy Ltd has traded between a low of ₹15.51 and a high of ₹34.49. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Prism Medico & Pharmacy Ltd has a market capitalization of approximately 40.39. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Prism Medico & Pharmacy Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -73.26 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 40.39 Cr, Prism Medico & Pharmacy Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Prism Medico & Pharmacy Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Prism Medico & Pharmacy Ltd is -73.26. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.